Citigroup Portfolio holdings
Citigroup Inc., formed in 1998 through the landmark merger of Citicorp and Travelers Group, with roots tracing back to the 1812 founding of City Bank of New York, is a global financial powerhouse headquartered in New York City, managing trillions in assets. Operating in over 160 countries, Citigroup offers a broad spectrum of services, including consumer banking (via Citibank), investment banking, wealth management, and trading, serving millions of retail customers and major corporations, governments, and institutions worldwide. Under CEO Jane Fraser since 2021—the first woman to lead a major U.S. bank—Citigroup has focused on streamlining operations, exiting consumer banking in 13 markets to bolster its institutional and wealth management focus, while navigating post-2008 regulatory scrutiny and fines. Known for its vast global footprint and resilience through crises, Citigroup remains a key player in international finance, blending retail accessibility with high-stakes capital markets expertise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Intel
INTC
|
+$436M |
| 2 |
United Therapeutics
UTHR
|
+$393M |
| 3 |
Amazon
AMZN
|
+$376M |
| 4 |
iShares Russell 2000 ETF
IWM
|
+$372M |
| 5 |
Visa
V
|
+$364M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI EAFE ETF
EFA
|
+$313M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$272M |
| 3 |
Stellantis
STLA
|
+$222M |
| 4 |
TSMC
TSM
|
+$215M |
| 5 |
Bank of America
BAC
|
+$184M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.76% |
| 2 | Consumer Discretionary | 6.77% |
| 3 | Healthcare | 6.2% |
| 4 | Financials | 5.48% |
| 5 | Communication Services | 4.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2926
PMV Pharmaceuticals
PMVP
$60.3M
| $835K | ﹤0.01% |
515,629
-7,094
| -1% | -$12.8K |
|
2927
Immunovant
IMVT
$8.11B
| $834K | ﹤0.01% |
31,595
-218,196
| -87% | -$6.21M |
|
|
UNIT
2928
Uniti Group
UNIT
$2.26B
| $834K | ﹤0.01% |
285,511
+10,047
| +4% | +$42.1K |
|
2929
Marten Transport
MRTN
$1.21B
| $832K | ﹤0.01% |
45,078
+6,071
| +16% | +$106K |
|
2930
iShares Core S&P US Growth ETF
IUSG
$31.3B
| $831K | ﹤0.01% |
6,516
-15,461
| -70% | -$1.84M |
|
2931
Procept Biorobotics
PRCT
$1.02B
| $830K | ﹤0.01% |
13,593
+2,750
| +25% | +$164K |
|
2932
Vestis
VSTS
$1.93B
| $830K | ﹤0.01% |
67,882
-111,112
| -62% | -$1.61M |
|
2933
iShares Morningstar US Equity ETF
ILCB
$1.26B
| $830K | ﹤0.01% |
11,039
+147
| +1% | +$10.6K |
|
|
REVG
2934
DELISTED
REV Group
REVG
| $829K | ﹤0.01% |
33,323
+25,547
| +329% | +$627K |
|
2935
MGP Ingredients
MGPI
$380M
| $829K | ﹤0.01% |
11,137
+1,212
| +12% | +$94.6K |
|
2936
PUT
Herbalife
HLF
$1.29B
| $826K | ﹤0.01% |
+79,500
| New | +$794K |
|
|
SAVE
2937
DELISTED
Spirit Airlines, Inc.
SAVE
| $826K | ﹤0.01% |
225,660
-105,491
| -32% | -$408K |
|
2938
Beazer Homes USA
BZH
$891M
| $825K | ﹤0.01% |
30,006
+2,620
| +10% | +$74.3K |
|
2939
Federal Agricultural Mortgage
AGM
$2.39B
| $824K | ﹤0.01% |
4,556
-3,902
| -46% | -$704K |
|
2940
Rhythm Pharmaceuticals
RYTM
$7.25B
| $821K | ﹤0.01% |
19,992
-170,528
| -90% | -$6.81M |
|
2941
Marqeta
MQ
$1.86B
| $821K | ﹤0.01% |
37,432
+1,676
| +5% | +$36.9K |
|
2942
Jack in the Box
JACK
$312M
| $818K | ﹤0.01% |
16,060
-49,433
| -75% | -$2.78M |
|
2943
Old Second Bancorp
OSBC
$1.29B
| $818K | ﹤0.01% |
55,202
+5,094
| +10% | +$71.7K |
|
2944
CALL
Viking Therapeutics
VKTX
$3.84B
| $816K | ﹤0.01% |
+15,400
| New | +$1.01M |
|
2945
Crane Co
CR
$12.4B
| $805K | ﹤0.01% |
5,554
+820
| +17% | +$116K |
|
2946
Cognyte Software
CGNT
$647M
| $805K | ﹤0.01% |
105,379
-15,823
| -13% | -$118K |
|
2947
CALL
Jabil
JBL
$32.3B
| $805K | ﹤0.01% |
7,400
-50,000
| -87% | -$6.06M |
|
2948
Coherus Oncology
CHRS
$227M
| $804K | ﹤0.01% |
464,455
-52,261
| -10% | -$105K |
|
|
FBRT
2949
Franklin BSP Realty Trust
FBRT
$596M
| $803K | ﹤0.01% |
63,711
+7,169
| +13% | +$91.3K |
|
2950
PUT
Cameco
CCJ
$38.4B
| $802K | ﹤0.01% |
+16,300
| New | +$826K |
|
Similar funds
Citigroup's Q2 2024 Portfolio in Review
As of Q2 2024, Citigroup held 5,888 positions worth $156B, up 2.5% from $152B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Citigroup's Q2 2024 filing shows 274 new, 2,819 increased, 1,798 reduced and 330 closed positions. Its largest new stake was Ferrovial N.V. Ordinary Shares: 8,935,948 shares worth $344M. The largest sale was iShares MSCI EAFE ETF, an estimated $313M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 16% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- Citigroup's largest Q2 2024 buy was Ferrovial N.V. Ordinary Shares: 8,935,948 shares worth $344M.
- Citigroup added most to Intel in Q2 2024, an estimated $436M increase.
- Citigroup's biggest Q2 2024 reduction was iShares MSCI EAFE ETF, cutting an estimated $313M.
- Citigroup fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $79.7M.
- Citigroup's ten largest holdings make up 22% of its $156B portfolio in Q2 2024.
- Citigroup opened 274 new positions and closed 330 in Q2 2024.
- Citigroup's portfolio value rose 2.5% quarter-over-quarter to $156B.
Based on Citigroup's 13F filing for Q2 2024, filed 12 Aug 2024.